express scripts glp 1 coverage change ibx Insurance just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. https://www.wfla.com/news/national/glp-1-insurance-change-impacts-millions-of-americans-what-to Express Scripts to stop covering

Common GLP-1 Agonists Here is a list of some of the most common GLP-1 medications approved by the FDA: For Type 2 Diabetes: Adlyxin (lixisenatide) Ozempic (semaglutide) Rybelsus (semaglutide, oral tablet) Trulicity (dulaglutide) Victoza (liraglutide) Combination medications like Soliqua Vial (lixisenatide and insulin glargine) For Obesity: Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Numerous other states are considering adding these medications because of the potential benefits of reducing obesity and the health complications it may prompt

Yarizadh H, Shab-Bidar S, Zamani B, Vanani AN, Baharlooi H, Djafarian K

These medications, initially approved by the FDA for diabetes management under names like Ozempic (semaglutide) and Monjaro (tirzepatide), are now being used to combat obesity

It can be even harder to get them to take their vitamins

Sclerotome The embryonic tissue that gives rise to the skeleton

Informational content only not medical advice